Unusual complication of vemurafenib treatment of metastatic melanoma: exacerbation of acantholytic dyskeratosis complicated by Kaposi varicelliform eruption.
Monique
M
Gupta
Victor
V
Huang
Gerry
G
Linette
Lynn
L
Cornelius
D000051:Acantholysis / Q000139:chemically induced* / Q000150:complications; D000368:Aged; D000970:Antineoplastic Agents / Q000009:adverse effects; D003875:Drug Eruptions / Q000209:etiology; D005260:Female; D006801:Humans; D007057:Ichthyosis / Q000139:chemically induced* / Q000150:complications; D007211:Indoles / Q000009:adverse effects*; D007617:Kaposi Varicelliform Eruption / Q000139:chemically induced* / Q000150:complications; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000556:secondary; D008545:Melanoma / Q000188:drug therapy* / Q000556:secondary; D012878:Skin Neoplasms / Q000188:drug therapy* / Q000473:pathology; D013449:Sulfonamides / Q000009:adverse effects*; D000077484:Vemurafenib
D000970:Antineoplastic Agents; D007211:Indoles; D013449:Sulfonamides; D000077484:Vemurafenib